CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON’S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA’S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES

Kevin McFarthing, Neha Prakash, Tanya Simuni

Journal of Parkinson s Disease · 2019 · 29 citations · 10 references

DOIFull text

Open access

Concepts

Abstract

252 1. Change in "On time" without troublesome dyskinesia during waking hours. 2. Change in the number of total daily LD doses. 3. Clinical Global Impression Improvement (CGI-I), as recorded by physician & patient. 4. Change in total UPDRS Score (sum of Parts I-III).

References

10